Literature DB >> 22045456

In vivo induction of interferon gamma expression in grey horses with metastatic melanoma resulting from direct injection of plasmid DNA coding for equine interleukin 12.

J-M V Müller1, J Wissemann, M L Meli, G Dasen, H Lutz, L Heinzerling, K Feige.   

Abstract

Whole blood pharmacokinetics of intratumourally injected naked plasmid DNA coding for equine Interleukin 12 (IL-12) was assessed as a means of in vivo gene transfer in the treatment of melanoma in grey horses. The expression of induced interferon gamma (IFN-g) was evaluated in order to determine the pharmacodynamic properties of in vivo gene transduction. Seven grey horses bearing melanoma were injected intratumourally with 250 µg naked plasmid DNA coding for IL-12. Peripheral blood and biopsies from the injection site were taken at 13 time points until day 14 post injection (p.i.). Samples were analysed using quantitative real-time PCR. Plasmid DNA was quantified in blood samples and mRNA expression for IFN-g in tissue samples. Plasmid DNA showed fast elimination kinetics with more than 99 % of the plasmid disappearing within 36 hours. IFN-g expression increased quickly after IL-12 plasmid injection, but varied between individual horses. Intratumoural injection of plasmid DNA is a feasible method for inducing transgene expression in vivo. Biological activity of the transgene IL-12 was confirmed by measuring expression of IFN-g.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22045456     DOI: 10.1024/0036-7281/a000262

Source DB:  PubMed          Journal:  Schweiz Arch Tierheilkd        ISSN: 0036-7281            Impact factor:   0.845


  6 in total

Review 1.  Brief in vitro IL-12 conditioning of CD8 + T Cells for anticancer adoptive T cell therapy.

Authors:  Mohamed Labib Salem; Samar Salman; Ibrahim O Barnawi
Journal:  Cancer Immunol Immunother       Date:  2021-05-08       Impact factor: 6.968

2.  Intratumoral immunotherapy relies on B and T cell collaboration.

Authors:  Idit Sagiv-Barfi; Debra K Czerwinski; Tanaya Shree; Julian J K Lohmeyer; Ronald Levy
Journal:  Sci Immunol       Date:  2022-05-27

Review 3.  Localized Interleukin-12 for Cancer Immunotherapy.

Authors:  Khue G Nguyen; Maura R Vrabel; Siena M Mantooth; Jared J Hopkins; Ethan S Wagner; Taylor A Gabaldon; David A Zaharoff
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

4.  Safe and effective treatment of spontaneous neoplasms with interleukin 12 electro-chemo-gene therapy.

Authors:  Jeffry Cutrera; Glenn King; Pamela Jones; Kristin Kicenuik; Elias Gumpel; Xueqing Xia; Shulin Li
Journal:  J Cell Mol Med       Date:  2015-01-27       Impact factor: 5.310

Review 5.  Clinical trials of immunogene therapy for spontaneous tumors in companion animals.

Authors:  Gerardo Claudio Glikin; Liliana María Elena Finocchiaro
Journal:  ScientificWorldJournal       Date:  2014-11-17

Review 6.  IL-12 based gene therapy in veterinary medicine.

Authors:  Darja Pavlin; Maja Cemazar; Gregor Sersa; Natasa Tozon
Journal:  J Transl Med       Date:  2012-11-21       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.